{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T23:26:29Z","timestamp":1780701989716,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025894"],"award-info":[{"award-number":["2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025289"],"award-info":[{"award-number":["2025289"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016909"],"award-info":[{"award-number":["2016909"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.sapharm.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:57:06Z","timestamp":1725393426000},"page":"1110-1117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"PA","title":["Development of pharmacy-based best practices to support safer use and management of prescription opioids based on an e-Delphi methodology"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Y","family":"Walley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili V","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Prathivadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pene","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2024.09.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103785","article-title":"Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010-2018","volume":"108","author":"Gjersing","year":"2022","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.sapharm.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/ejp.1786","article-title":"Is Europe also facing an opioid crisis?-A survey of European Pain Federation chapters","volume":"25","author":"H\u00e4user","year":"2021","journal-title":"Eur J Pain"},{"key":"10.1016\/j.sapharm.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/bcp.12446","article-title":"An overview of the patterns of prescription opioid use, costs and related harms in Australia","volume":"78","author":"Blanch","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2024.09.001_bib5","article-title":"Opioid prescribing patterns among medical providers in the United States, 2003-17: retrospective, observational study","volume":"368","author":"Kiang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.sapharm.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2105\/AJPH.2018.304753","article-title":"Quantifying the adequacy of opioid analgesic consumption globally: an updated method and early findings","volume":"109","author":"Scholten","year":"2019","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.sapharm.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1007\/s11606-021-06799-1","article-title":"Learning from the opioid epidemic: preventing the next healthcare marketing crisis","volume":"36","author":"Uppal","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/add.13795","article-title":"Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001\u201312","volume":"112","author":"Hsu","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2024.09.001_bib10","volume":"vol. 2022","year":"2021"},{"key":"10.1016\/j.sapharm.2024.09.001_bib11","series-title":"Alcohol, Tobacco & Other Drugs in Australia","year":"2021"},{"key":"10.1016\/j.sapharm.2024.09.001_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3059","article-title":"Pharmaceutical opioid use patterns and indicators of extramedical use and harm in adults with chronic noncancer pain, 2012-2018","volume":"4","author":"Degenhardt","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.sapharm.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.sapharm.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.sapharm.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5694\/mja2.52002","article-title":"Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations","volume":"219","author":"Langford","year":"2023","journal-title":"Med J Aust"},{"key":"10.1016\/j.sapharm.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/add.15727","article-title":"The cost and impact of distributing naloxone to people who are prescribed opioids to prevent opioid-related deaths: findings from a modelling study","volume":"117","author":"Nielsen","year":"2022","journal-title":"Addiction"},{"key":"10.1016\/j.sapharm.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1007\/s11606-021-07356-6","article-title":"Naloxone Co-dispensing with opioids: a cluster randomized pragmatic trial","volume":"37","author":"Binswanger","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.sapharm.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7326\/M15-2771","article-title":"Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain","volume":"165","author":"Coffin","year":"2016","journal-title":"Ann Intern Med"},{"issue":"No","key":"10.1016\/j.sapharm.2024.09.001_bib19","first-page":"CD011117","article-title":"Opioid agonist treatment for people who are dependent on pharmaceutical opioids","volume":"9","author":"Nielsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2024.09.001_bib20","unstructured":"The Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice, Part A. http:\/\/www.racgp.org.au\/download\/Documents\/Guidelines\/Addictive-drugs\/Addictive-drugs-guide-A.pdf2015."},{"key":"10.1016\/j.sapharm.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/SAR.S351096","article-title":"The role of the pharmacist in combating the opioid crisis: an update","volume":"13","author":"Kosobuski","year":"2022","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.sapharm.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Sci Clin Pract"},{"key":"10.1016\/j.sapharm.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-015-0058-x","article-title":"Orienting patients to greater opioid safety: models of community pharmacy-based naloxone","volume":"12","author":"Green","year":"2015","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.sapharm.2024.09.001_bib24","first-page":"478","article-title":"Pharmacists and the opioid crisis: a narrative review of pharmacists' practice roles","volume":"3","author":"Bratberg","year":"2020","journal-title":"JACCP: J American Coll Clin Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/SAR.S144268","article-title":"The opioid overdose epidemic: opportunities for pharmacists","volume":"8","author":"Wu","year":"2017","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.sapharm.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.sapharm.2019.01.017","article-title":"Challenges faced with opioid prescriptions in the community setting \u2013 Australian pharmacists' perspectives","volume":"15","author":"Makdessi","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.sapharm.2020.02.009","article-title":"Routine opioid outcome monitoring in community pharmacy: outcomes from an open-label single-arm implementation-effectiveness pilot study","volume":"16","author":"Nielsen","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jac5.1579","article-title":"Pharmacists' role in buprenorphine management for opioid use disorder: a narrative review","volume":"5","author":"Cleary","year":"2022","journal-title":"J American Coll Clin Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4066\/AMJ.2011.706","article-title":"Provision of opioid substitution therapy services in Australian pharmacies","volume":"4","author":"Chaar","year":"2011","journal-title":"Australas Med J"},{"key":"10.1016\/j.sapharm.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1360-0443.2002.00241.x","article-title":"Community pharmacy services for drug misusers in Scotland: what difference does 5 years make?","volume":"97","author":"Matheson","year":"2002","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.sapharm.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/YCO.0000000000000943","article-title":"Pharmacist-prescriber collaborative models of care for opioid use disorder: an overview of recent research","volume":"37","author":"Cheetham","year":"2024","journal-title":"Curr Opin Psychiatr"},{"key":"10.1016\/j.sapharm.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ijpp\/riad090","article-title":"Factors influencing pharmacists' roles in preventing prescription and over-the-counter opioid misuse: a systematic review and narrative synthesis","volume":"32","author":"Offu","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: how to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Methodol"},{"key":"10.1016\/j.sapharm.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2648.1994.tb01066.x","article-title":"The Delphi technique: a methodological discussion","volume":"19","author":"Williams","year":"1994","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.sapharm.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2648.2006.03716.x","article-title":"Consulting the oracle: ten lessons from using the Delphi technique in nursing research","volume":"53","author":"Keeney","year":"2006","journal-title":"J Adv Nurs"},{"key":"10.1016\/j.sapharm.2024.09.001_bib36","series-title":"Using an E-Delphi Technique in Achieving Consensus across Disciplines for Developing Best Practice in Day Surgery in Ireland","author":"Meshkat","year":"2021"},{"key":"10.1016\/j.sapharm.2024.09.001_bib37","first-page":"12","article-title":"The Delphi technique: making sense of consensus","author":"Hsu","year":"2007","journal-title":"Practical Assess Res Eval"},{"key":"10.1016\/j.sapharm.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/0142159X.2017.1245856","article-title":"Using consensus group methods such as Delphi and Nominal Group in medical education research","volume":"39","author":"Humphrey-Murto","year":"2017","journal-title":"Med Teach"},{"key":"10.1016\/j.sapharm.2024.09.001_bib39","series-title":"ThINC-3 Naloxone Conference","year":"2023"},{"key":"10.1016\/j.sapharm.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"key":"10.1016\/j.sapharm.2024.09.001_bib41","series-title":"R: A Language and Environment for Statistical Computing","year":"2022"},{"key":"10.1016\/j.sapharm.2024.09.001_bib42","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1016\/j.sapharm.2021.06.018","article-title":"The role of pharmacists in opioid stewardship: a scoping review","volume":"18","author":"Gondora","year":"2022","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/SAR.S351096","article-title":"The role of the pharmacist in combating the opioid crisis: an update","author":"Kosobuski","year":"2022","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.sapharm.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.sapharm.2019.01.002","article-title":"Pharmacist utilization of prescription opioid misuse interventions: acceptability among pharmacists and patients","volume":"15","author":"Riley","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib45","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.sapharm.2021.07.012","article-title":"Pharmacist interventions to deprescribe opioids and benzodiazepines in older adults: a rapid review","volume":"18","author":"Niznik","year":"2022","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.09.001_bib46","series-title":"Intelligent Systems for Sustainable Person-Centered Healthcare","first-page":"53","article-title":"Person-centred care interventions in pharmaceutical care","author":"Marinkovic","year":"2022"},{"key":"10.1016\/j.sapharm.2024.09.001_bib47","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ijerph17020536","article-title":"The community pharmacist: perceived barriers and patient-centered care communication","volume":"17","author":"Ilardo","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.sapharm.2024.09.001_bib48","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcp.14947","article-title":"Community\u2010based pharmacists' role in deprescribing: a systematic review","volume":"88","author":"Bu\u017ean\u010di\u0107","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ijpp\/riad025","article-title":"A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy","volume":"31","author":"Omuya","year":"2023","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2024.09.001_bib51","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","article-title":"From best evidence to best practice: effective implementation of change in patients' care","volume":"362","author":"Grol","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2024.09.001_bib52","article-title":"Opioid agonist treatment for people who are dependent on pharmaceutical opioids","volume":"9","author":"Nielsen","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.sapharm.2024.09.001_bib53","series-title":"Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard","year":"2022"},{"key":"10.1016\/j.sapharm.2024.09.001_bib54","series-title":"RAND Methodological Guidance for Conducting and Critically Appraising Delphi Panels","author":"Khodyakov","year":"2023"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124003498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124003498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:38:52Z","timestamp":1778618332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124003498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1551741124003498"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.09.001","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of pharmacy-based best practices to support safer use and management of prescription opioids based on an e-Delphi methodology","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}